MOL CANCER 润色咨询

Molecular Cancer

出版年份:2002 年文章数:971 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:2.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2194122, encodeId=7b5e21941225e, content=审稿速度:3.0<br>偏重的研究方向:cancer<br>经验分享:圣诞节前投的,三个月还是peer review,具体显示The editors' decision can take several weeks as they may consult peer reviewers., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2069031093, createdName=ms7000000762441132, createdTime=Tue Mar 19 17:13:04 CST 2024, time=2024-03-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了,大家有遇到这种情况吗,是稿件太多了处理不过来吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192414, encodeId=15d72192414e6, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;肿瘤化疗<br>经验分享:现在硬投一篇molecular cancer research系列文章已经相当不容易了。当然,该杂志上面还有一些no ncoding RNA的关系稿,水平很低。虽说大CDD,nature com,j of hepatology, cancer research,advanced science等也时不时也些关系稿,但文章水平也差不了太多。就这点,希望molecular cancer杂志能过改进。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Mar 10 19:25:13 CST 2024, time=2024-03-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1003000, encodeId=82231003000b1, content=under review21天,又回到editor assigned状态,有同志有类似情况吗?求解,万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfaa5456833, createdName=Medicalresearch, createdTime=Tue Jul 27 14:14:25 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108857, encodeId=d0a5210885eea, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:circRNA<br>经验分享:2022.3月投的,现在还没审完!请不到审稿人就倒闭算了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53508283991, createdName=ms4000001414066014, createdTime=Thu Jan 05 02:33:12 CST 2023, time=2023-01-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183036, encodeId=e8f421830362e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投了一篇大综述,被nature cancer 拒下来的,审稿两个月给了小修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad038147437, createdName=ms9000001581615796, createdTime=Sun Jan 21 19:51:36 CST 2024, time=2024-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向:肿瘤生物学<br>经验分享:1.7投了一篇综述,看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向:肿瘤;血管新生<br>经验分享:投稿三天,一直是editor appointed, 这个状态会持续多久呢,下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:求问已投稿的各位仁兄,editor appointed这个状态多久之后编辑会做出下一步决定呢?目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京)]
    2024-03-19 ms7000000762441132 来自河南省

    审稿速度:3.0
    偏重的研究方向:cancer
    经验分享:圣诞节前投的,三个月还是peer review,具体显示The editors' decision can take several weeks as they may consult peer reviewers.

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2194122, encodeId=7b5e21941225e, content=审稿速度:3.0<br>偏重的研究方向:cancer<br>经验分享:圣诞节前投的,三个月还是peer review,具体显示The editors' decision can take several weeks as they may consult peer reviewers., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2069031093, createdName=ms7000000762441132, createdTime=Tue Mar 19 17:13:04 CST 2024, time=2024-03-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了,大家有遇到这种情况吗,是稿件太多了处理不过来吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192414, encodeId=15d72192414e6, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;肿瘤化疗<br>经验分享:现在硬投一篇molecular cancer research系列文章已经相当不容易了。当然,该杂志上面还有一些no ncoding RNA的关系稿,水平很低。虽说大CDD,nature com,j of hepatology, cancer research,advanced science等也时不时也些关系稿,但文章水平也差不了太多。就这点,希望molecular cancer杂志能过改进。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Mar 10 19:25:13 CST 2024, time=2024-03-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1003000, encodeId=82231003000b1, content=under review21天,又回到editor assigned状态,有同志有类似情况吗?求解,万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfaa5456833, createdName=Medicalresearch, createdTime=Tue Jul 27 14:14:25 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108857, encodeId=d0a5210885eea, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:circRNA<br>经验分享:2022.3月投的,现在还没审完!请不到审稿人就倒闭算了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53508283991, createdName=ms4000001414066014, createdTime=Thu Jan 05 02:33:12 CST 2023, time=2023-01-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183036, encodeId=e8f421830362e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投了一篇大综述,被nature cancer 拒下来的,审稿两个月给了小修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad038147437, createdName=ms9000001581615796, createdTime=Sun Jan 21 19:51:36 CST 2024, time=2024-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向:肿瘤生物学<br>经验分享:1.7投了一篇综述,看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向:肿瘤;血管新生<br>经验分享:投稿三天,一直是editor appointed, 这个状态会持续多久呢,下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:求问已投稿的各位仁兄,editor appointed这个状态多久之后编辑会做出下一步决定呢?目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京)]
    2024-01-10 1464d723m79暂无昵称 来自广东省

    Editor appointed一个月了,大家有遇到这种情况吗,是稿件太多了处理不过来吗?

    5

    展开5条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2194122, encodeId=7b5e21941225e, content=审稿速度:3.0<br>偏重的研究方向:cancer<br>经验分享:圣诞节前投的,三个月还是peer review,具体显示The editors' decision can take several weeks as they may consult peer reviewers., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2069031093, createdName=ms7000000762441132, createdTime=Tue Mar 19 17:13:04 CST 2024, time=2024-03-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了,大家有遇到这种情况吗,是稿件太多了处理不过来吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192414, encodeId=15d72192414e6, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;肿瘤化疗<br>经验分享:现在硬投一篇molecular cancer research系列文章已经相当不容易了。当然,该杂志上面还有一些no ncoding RNA的关系稿,水平很低。虽说大CDD,nature com,j of hepatology, cancer research,advanced science等也时不时也些关系稿,但文章水平也差不了太多。就这点,希望molecular cancer杂志能过改进。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Mar 10 19:25:13 CST 2024, time=2024-03-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1003000, encodeId=82231003000b1, content=under review21天,又回到editor assigned状态,有同志有类似情况吗?求解,万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfaa5456833, createdName=Medicalresearch, createdTime=Tue Jul 27 14:14:25 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108857, encodeId=d0a5210885eea, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:circRNA<br>经验分享:2022.3月投的,现在还没审完!请不到审稿人就倒闭算了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53508283991, createdName=ms4000001414066014, createdTime=Thu Jan 05 02:33:12 CST 2023, time=2023-01-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183036, encodeId=e8f421830362e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投了一篇大综述,被nature cancer 拒下来的,审稿两个月给了小修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad038147437, createdName=ms9000001581615796, createdTime=Sun Jan 21 19:51:36 CST 2024, time=2024-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向:肿瘤生物学<br>经验分享:1.7投了一篇综述,看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向:肿瘤;血管新生<br>经验分享:投稿三天,一直是editor appointed, 这个状态会持续多久呢,下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:求问已投稿的各位仁兄,editor appointed这个状态多久之后编辑会做出下一步决定呢?目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京)]
    2024-03-10 1811e984f8m 来自安徽省

    审稿速度:2.0 | 投稿命中率:5.0
    偏重的研究方向:肿瘤;肿瘤化疗
    经验分享:现在硬投一篇molecular cancer research系列文章已经相当不容易了。当然,该杂志上面还有一些no ncoding RNA的关系稿,水平很低。虽说大CDD,nature com,j of hepatology, cancer research,advanced science等也时不时也些关系稿,但文章水平也差不了太多。就这点,希望molecular cancer杂志能过改进。

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2194122, encodeId=7b5e21941225e, content=审稿速度:3.0<br>偏重的研究方向:cancer<br>经验分享:圣诞节前投的,三个月还是peer review,具体显示The editors' decision can take several weeks as they may consult peer reviewers., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2069031093, createdName=ms7000000762441132, createdTime=Tue Mar 19 17:13:04 CST 2024, time=2024-03-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了,大家有遇到这种情况吗,是稿件太多了处理不过来吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192414, encodeId=15d72192414e6, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;肿瘤化疗<br>经验分享:现在硬投一篇molecular cancer research系列文章已经相当不容易了。当然,该杂志上面还有一些no ncoding RNA的关系稿,水平很低。虽说大CDD,nature com,j of hepatology, cancer research,advanced science等也时不时也些关系稿,但文章水平也差不了太多。就这点,希望molecular cancer杂志能过改进。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Mar 10 19:25:13 CST 2024, time=2024-03-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1003000, encodeId=82231003000b1, content=under review21天,又回到editor assigned状态,有同志有类似情况吗?求解,万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfaa5456833, createdName=Medicalresearch, createdTime=Tue Jul 27 14:14:25 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108857, encodeId=d0a5210885eea, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:circRNA<br>经验分享:2022.3月投的,现在还没审完!请不到审稿人就倒闭算了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53508283991, createdName=ms4000001414066014, createdTime=Thu Jan 05 02:33:12 CST 2023, time=2023-01-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183036, encodeId=e8f421830362e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投了一篇大综述,被nature cancer 拒下来的,审稿两个月给了小修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad038147437, createdName=ms9000001581615796, createdTime=Sun Jan 21 19:51:36 CST 2024, time=2024-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向:肿瘤生物学<br>经验分享:1.7投了一篇综述,看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向:肿瘤;血管新生<br>经验分享:投稿三天,一直是editor appointed, 这个状态会持续多久呢,下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:求问已投稿的各位仁兄,editor appointed这个状态多久之后编辑会做出下一步决定呢?目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京)]
    2021-07-27 Medicalresearch

    under review21天,又回到editor assigned状态,有同志有类似情况吗?求解,万分感谢

    7

    展开7条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2194122, encodeId=7b5e21941225e, content=审稿速度:3.0<br>偏重的研究方向:cancer<br>经验分享:圣诞节前投的,三个月还是peer review,具体显示The editors' decision can take several weeks as they may consult peer reviewers., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2069031093, createdName=ms7000000762441132, createdTime=Tue Mar 19 17:13:04 CST 2024, time=2024-03-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了,大家有遇到这种情况吗,是稿件太多了处理不过来吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192414, encodeId=15d72192414e6, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;肿瘤化疗<br>经验分享:现在硬投一篇molecular cancer research系列文章已经相当不容易了。当然,该杂志上面还有一些no ncoding RNA的关系稿,水平很低。虽说大CDD,nature com,j of hepatology, cancer research,advanced science等也时不时也些关系稿,但文章水平也差不了太多。就这点,希望molecular cancer杂志能过改进。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Mar 10 19:25:13 CST 2024, time=2024-03-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1003000, encodeId=82231003000b1, content=under review21天,又回到editor assigned状态,有同志有类似情况吗?求解,万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfaa5456833, createdName=Medicalresearch, createdTime=Tue Jul 27 14:14:25 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108857, encodeId=d0a5210885eea, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:circRNA<br>经验分享:2022.3月投的,现在还没审完!请不到审稿人就倒闭算了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53508283991, createdName=ms4000001414066014, createdTime=Thu Jan 05 02:33:12 CST 2023, time=2023-01-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183036, encodeId=e8f421830362e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投了一篇大综述,被nature cancer 拒下来的,审稿两个月给了小修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad038147437, createdName=ms9000001581615796, createdTime=Sun Jan 21 19:51:36 CST 2024, time=2024-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向:肿瘤生物学<br>经验分享:1.7投了一篇综述,看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向:肿瘤;血管新生<br>经验分享:投稿三天,一直是editor appointed, 这个状态会持续多久呢,下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:求问已投稿的各位仁兄,editor appointed这个状态多久之后编辑会做出下一步决定呢?目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京)]
    2023-01-05 ms4000001414066014 来自河南省

    审稿速度:12.0 | 投稿命中率:25.0
    偏重的研究方向:circRNA
    经验分享:2022.3月投的,现在还没审完!请不到审稿人就倒闭算了

    8

    展开8条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2194122, encodeId=7b5e21941225e, content=审稿速度:3.0<br>偏重的研究方向:cancer<br>经验分享:圣诞节前投的,三个月还是peer review,具体显示The editors' decision can take several weeks as they may consult peer reviewers., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2069031093, createdName=ms7000000762441132, createdTime=Tue Mar 19 17:13:04 CST 2024, time=2024-03-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了,大家有遇到这种情况吗,是稿件太多了处理不过来吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192414, encodeId=15d72192414e6, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;肿瘤化疗<br>经验分享:现在硬投一篇molecular cancer research系列文章已经相当不容易了。当然,该杂志上面还有一些no ncoding RNA的关系稿,水平很低。虽说大CDD,nature com,j of hepatology, cancer research,advanced science等也时不时也些关系稿,但文章水平也差不了太多。就这点,希望molecular cancer杂志能过改进。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Mar 10 19:25:13 CST 2024, time=2024-03-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1003000, encodeId=82231003000b1, content=under review21天,又回到editor assigned状态,有同志有类似情况吗?求解,万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfaa5456833, createdName=Medicalresearch, createdTime=Tue Jul 27 14:14:25 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108857, encodeId=d0a5210885eea, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:circRNA<br>经验分享:2022.3月投的,现在还没审完!请不到审稿人就倒闭算了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53508283991, createdName=ms4000001414066014, createdTime=Thu Jan 05 02:33:12 CST 2023, time=2023-01-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183036, encodeId=e8f421830362e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投了一篇大综述,被nature cancer 拒下来的,审稿两个月给了小修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad038147437, createdName=ms9000001581615796, createdTime=Sun Jan 21 19:51:36 CST 2024, time=2024-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向:肿瘤生物学<br>经验分享:1.7投了一篇综述,看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向:肿瘤;血管新生<br>经验分享:投稿三天,一直是editor appointed, 这个状态会持续多久呢,下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:求问已投稿的各位仁兄,editor appointed这个状态多久之后编辑会做出下一步决定呢?目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京)]
    2022-05-18 14672ee2m82暂无昵称

    老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗

    7

    展开7条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2194122, encodeId=7b5e21941225e, content=审稿速度:3.0<br>偏重的研究方向:cancer<br>经验分享:圣诞节前投的,三个月还是peer review,具体显示The editors' decision can take several weeks as they may consult peer reviewers., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2069031093, createdName=ms7000000762441132, createdTime=Tue Mar 19 17:13:04 CST 2024, time=2024-03-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了,大家有遇到这种情况吗,是稿件太多了处理不过来吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192414, encodeId=15d72192414e6, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;肿瘤化疗<br>经验分享:现在硬投一篇molecular cancer research系列文章已经相当不容易了。当然,该杂志上面还有一些no ncoding RNA的关系稿,水平很低。虽说大CDD,nature com,j of hepatology, cancer research,advanced science等也时不时也些关系稿,但文章水平也差不了太多。就这点,希望molecular cancer杂志能过改进。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Mar 10 19:25:13 CST 2024, time=2024-03-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1003000, encodeId=82231003000b1, content=under review21天,又回到editor assigned状态,有同志有类似情况吗?求解,万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfaa5456833, createdName=Medicalresearch, createdTime=Tue Jul 27 14:14:25 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108857, encodeId=d0a5210885eea, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:circRNA<br>经验分享:2022.3月投的,现在还没审完!请不到审稿人就倒闭算了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53508283991, createdName=ms4000001414066014, createdTime=Thu Jan 05 02:33:12 CST 2023, time=2023-01-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183036, encodeId=e8f421830362e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投了一篇大综述,被nature cancer 拒下来的,审稿两个月给了小修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad038147437, createdName=ms9000001581615796, createdTime=Sun Jan 21 19:51:36 CST 2024, time=2024-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向:肿瘤生物学<br>经验分享:1.7投了一篇综述,看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向:肿瘤;血管新生<br>经验分享:投稿三天,一直是editor appointed, 这个状态会持续多久呢,下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:求问已投稿的各位仁兄,editor appointed这个状态多久之后编辑会做出下一步决定呢?目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京)]
    2024-01-21 ms9000001581615796 来自江苏省

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:投了一篇大综述,被nature cancer 拒下来的,审稿两个月给了小修

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2194122, encodeId=7b5e21941225e, content=审稿速度:3.0<br>偏重的研究方向:cancer<br>经验分享:圣诞节前投的,三个月还是peer review,具体显示The editors' decision can take several weeks as they may consult peer reviewers., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2069031093, createdName=ms7000000762441132, createdTime=Tue Mar 19 17:13:04 CST 2024, time=2024-03-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了,大家有遇到这种情况吗,是稿件太多了处理不过来吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192414, encodeId=15d72192414e6, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;肿瘤化疗<br>经验分享:现在硬投一篇molecular cancer research系列文章已经相当不容易了。当然,该杂志上面还有一些no ncoding RNA的关系稿,水平很低。虽说大CDD,nature com,j of hepatology, cancer research,advanced science等也时不时也些关系稿,但文章水平也差不了太多。就这点,希望molecular cancer杂志能过改进。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Mar 10 19:25:13 CST 2024, time=2024-03-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1003000, encodeId=82231003000b1, content=under review21天,又回到editor assigned状态,有同志有类似情况吗?求解,万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfaa5456833, createdName=Medicalresearch, createdTime=Tue Jul 27 14:14:25 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108857, encodeId=d0a5210885eea, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:circRNA<br>经验分享:2022.3月投的,现在还没审完!请不到审稿人就倒闭算了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53508283991, createdName=ms4000001414066014, createdTime=Thu Jan 05 02:33:12 CST 2023, time=2023-01-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183036, encodeId=e8f421830362e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投了一篇大综述,被nature cancer 拒下来的,审稿两个月给了小修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad038147437, createdName=ms9000001581615796, createdTime=Sun Jan 21 19:51:36 CST 2024, time=2024-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向:肿瘤生物学<br>经验分享:1.7投了一篇综述,看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向:肿瘤;血管新生<br>经验分享:投稿三天,一直是editor appointed, 这个状态会持续多久呢,下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:求问已投稿的各位仁兄,editor appointed这个状态多久之后编辑会做出下一步决定呢?目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京)]
    2024-01-08 P拾荒者 来自浙江省

    偏重的研究方向:肿瘤生物学
    经验分享:1.7投了一篇综述,看看多久拒稿

    5

    展开5条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2194122, encodeId=7b5e21941225e, content=审稿速度:3.0<br>偏重的研究方向:cancer<br>经验分享:圣诞节前投的,三个月还是peer review,具体显示The editors' decision can take several weeks as they may consult peer reviewers., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2069031093, createdName=ms7000000762441132, createdTime=Tue Mar 19 17:13:04 CST 2024, time=2024-03-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了,大家有遇到这种情况吗,是稿件太多了处理不过来吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192414, encodeId=15d72192414e6, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;肿瘤化疗<br>经验分享:现在硬投一篇molecular cancer research系列文章已经相当不容易了。当然,该杂志上面还有一些no ncoding RNA的关系稿,水平很低。虽说大CDD,nature com,j of hepatology, cancer research,advanced science等也时不时也些关系稿,但文章水平也差不了太多。就这点,希望molecular cancer杂志能过改进。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Mar 10 19:25:13 CST 2024, time=2024-03-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1003000, encodeId=82231003000b1, content=under review21天,又回到editor assigned状态,有同志有类似情况吗?求解,万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfaa5456833, createdName=Medicalresearch, createdTime=Tue Jul 27 14:14:25 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108857, encodeId=d0a5210885eea, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:circRNA<br>经验分享:2022.3月投的,现在还没审完!请不到审稿人就倒闭算了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53508283991, createdName=ms4000001414066014, createdTime=Thu Jan 05 02:33:12 CST 2023, time=2023-01-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183036, encodeId=e8f421830362e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投了一篇大综述,被nature cancer 拒下来的,审稿两个月给了小修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad038147437, createdName=ms9000001581615796, createdTime=Sun Jan 21 19:51:36 CST 2024, time=2024-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向:肿瘤生物学<br>经验分享:1.7投了一篇综述,看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向:肿瘤;血管新生<br>经验分享:投稿三天,一直是editor appointed, 这个状态会持续多久呢,下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:求问已投稿的各位仁兄,editor appointed这个状态多久之后编辑会做出下一步决定呢?目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京)]
    2022-09-21 14856b50m82暂无昵称

    偏重的研究方向:肿瘤;血管新生
    经验分享:投稿三天,一直是editor appointed, 这个状态会持续多久呢,下一步会是什么🤔

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2194122, encodeId=7b5e21941225e, content=审稿速度:3.0<br>偏重的研究方向:cancer<br>经验分享:圣诞节前投的,三个月还是peer review,具体显示The editors' decision can take several weeks as they may consult peer reviewers., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2069031093, createdName=ms7000000762441132, createdTime=Tue Mar 19 17:13:04 CST 2024, time=2024-03-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2180553, encodeId=7b172180553ec, content=Editor appointed一个月了,大家有遇到这种情况吗,是稿件太多了处理不过来吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8c5128063, createdName=1464d723m79暂无昵称, createdTime=Wed Jan 10 19:12:54 CST 2024, time=2024-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192414, encodeId=15d72192414e6, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;肿瘤化疗<br>经验分享:现在硬投一篇molecular cancer research系列文章已经相当不容易了。当然,该杂志上面还有一些no ncoding RNA的关系稿,水平很低。虽说大CDD,nature com,j of hepatology, cancer research,advanced science等也时不时也些关系稿,但文章水平也差不了太多。就这点,希望molecular cancer杂志能过改进。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Mar 10 19:25:13 CST 2024, time=2024-03-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1003000, encodeId=82231003000b1, content=under review21天,又回到editor assigned状态,有同志有类似情况吗?求解,万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfaa5456833, createdName=Medicalresearch, createdTime=Tue Jul 27 14:14:25 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108857, encodeId=d0a5210885eea, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:circRNA<br>经验分享:2022.3月投的,现在还没审完!请不到审稿人就倒闭算了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53508283991, createdName=ms4000001414066014, createdTime=Thu Jan 05 02:33:12 CST 2023, time=2023-01-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183036, encodeId=e8f421830362e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投了一篇大综述,被nature cancer 拒下来的,审稿两个月给了小修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad038147437, createdName=ms9000001581615796, createdTime=Sun Jan 21 19:51:36 CST 2024, time=2024-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179973, encodeId=b37d21e9973ad, content=偏重的研究方向:肿瘤生物学<br>经验分享:1.7投了一篇综述,看看多久拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Jan 08 15:19:18 CST 2024, time=2024-01-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向:肿瘤;血管新生<br>经验分享:投稿三天,一直是editor appointed, 这个状态会持续多久呢,下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0<br>偏重的研究方向:肿瘤<br>经验分享:求问已投稿的各位仁兄,editor appointed这个状态多久之后编辑会做出下一步决定呢?目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京)]
    2023-08-12 ms7000000365645384 来自北京

    审稿速度:6.0
    偏重的研究方向:肿瘤
    经验分享:求问已投稿的各位仁兄,editor appointed这个状态多久之后编辑会做出下一步决定呢?目前已4天

    1

    展开1条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分